<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03696095</url>
  </required_header>
  <id_info>
    <org_study_id>2018-000822-70</org_study_id>
    <nct_id>NCT03696095</nct_id>
  </id_info>
  <brief_title>Local Anesthetic Automated Intermittent Administration vs. Continuous Infusion Via Femoral Nerve Block.</brief_title>
  <official_title>Continuous Infusion vs. Programmed Intermittent Bolus of Ropivacaine Through Peri-neural Femoral Nerve Catheter After Total Knee Arthroplasty: Impact on Analgesia Quality and Motor Block Frequency.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>J P Lecoq</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the impact of local anesthetic administration regiment through
      peri-neural femoral nerve catheter on pain and motor block frequency, after total knee
      arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study evaluates the impact of local anesthetic administration regiment through
      peri-neural femoral nerve catheter on pain and motor block frequency, after total knee
      arthroplasty. One group of patients will receive automated intermittent bolus, while the
      others will get a continuous infusion. In both cases, patients will be able to administer
      supplementary auto-bolus if required.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 16, 2018</start_date>
  <completion_date type="Actual">December 6, 2018</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of unplanned analgesia interventions.</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>Composite criteria including the frequency of unplanned analgesia interventions administered by the patient, or paramedical and medical staff, and by extenstion the total amount of opioids (in milligrams equivalent morphine) and local anesthetics (in milligrams) received in post-operative period.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain difference</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>Pain difference accessed by Numeric Pain Rating Scale (0-10), twice a day, at rest and on movement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor block frequency</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>Accessed by physiotherapist twice a day, by testing the Quadriceps muscle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobilization quality during physiotherapy sessions.</measure>
    <time_frame>up to 72 hours after surgery</time_frame>
    <description>accessed by physiotherapist, ability to walk with or without help, take stairs, and flex and extend knee (comparatively to the opposite knee).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>local anesthesia technique related complications</measure>
    <time_frame>until catheter removal 48 hours after surgery</time_frame>
    <description>rate of complications including: hematoma, infection, catheter dislodgement or breakage, allergic events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>Continous infusion ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Continuous infusion via peri-neural femoral nerve catheter of Ropivacaine Hcl 0.2% Inj Bag 200Ml (CI mode) at rate of 6ml/h + patient controlled bolus of 3ml ...</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PIB ropivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Programmed intermittent bolus of Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode) : 6ml each 60min + patient controlled bolus 3ml ...</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine Hcl 0.2% Inj Bag 200Ml (PIB mode)</intervention_name>
    <description>programmed intermittent bolus 5ml each one hour.</description>
    <arm_group_label>PIB ropivacaine</arm_group_label>
    <other_name>PIB</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine Hcl 0.2% Inj Bag 200Ml (CI mode)</intervention_name>
    <description>continuous infusion 6ml/h</description>
    <arm_group_label>Continous infusion ropivacaine</arm_group_label>
    <other_name>Continuous infusion</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  admitted for unilateral primary total knee arthroplasty.

        Exclusion Criteria:

          -  ASA score &gt; 3

          -  BMI &gt; 40

          -  refusal of loco-regional technique.

          -  psychiatric disease.

          -  inability to understand/ use the Local anesthetic delivery pump.

          -  local anesthetic allergy,

          -  porphyry,

          -  uncontrolled epilepsy,

          -  severe cardiac arrhythmia.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annis Orfi</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Liege</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Liege</name>
      <address>
        <city>Li√®ge</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>September 28, 2018</study_first_submitted>
  <study_first_submitted_qc>October 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2018</study_first_posted>
  <last_update_submitted>January 24, 2019</last_update_submitted>
  <last_update_submitted_qc>January 24, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>J P Lecoq</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>programmed intermittent bolus</keyword>
  <keyword>Continuous femoral nerve block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

